Management of Infants with a Positive Direct Antiglobulin Test (DAT)

Initial Evaluation

Obtain a complete laboratory work‑up immediately – total and direct bilirubin, CBC with smear, reticulocyte count, infant and maternal ABO/Rh typing, serum albumin, and G6PD activity when the cause of jaundice is unclear. (American Academy of Pediatrics) 1
Low serum albumin (< 3.0 g/dL) markedly increases the risk of bilirubin‑induced neurotoxicity and should be identified early. (American Academy of Pediatrics) [2][3]
Maternal antibodies can remain bound to the infant’s red cells for up to 6 months, indicating ongoing hemolysis risk. (American College of Obstetricians and Gynecologists) 5

TSB ≥ 20 mg/dL (342 µmol/L) at any age, or ≥ 25 mg/dL (428 µmol/L) at any time, constitutes a medical emergency requiring hospital admission for intensive phototherapy. (American Academy of Pediatrics) [1][6]
A bilirubin rise of ≥ 0.2 mg/dL per hour after the first 24 h of life signals active hemolysis and warrants prompt escalation. (American Academy of Pediatrics) 4
Persistent increase in TSB despite intensive phototherapy indicates severe hemolysis and the need for additional interventions. (American Academy of Pediatrics) [1][6]

Start intensive phototherapy using hour‑specific nomograms with lower thresholds for DAT‑positive infants to prevent kernicterus. (American Academy of Pediatrics) [4][1]
Monitor TSB every 4–12 h; increase frequency to every 2–3 h when TSB reaches 20–25 mg/dL to detect rapid changes. (American Academy of Pediatrics) [1][6]
Continue breastfeeding every 2–3 h during phototherapy to maintain hydration and caloric intake. (American Academy of Pediatrics) [2][6]

Administer IVIG 0.5–1 g/kg over 2 h when TSB rises despite intensive phototherapy or is within 2–3 mg/dL of the exchange‑transfusion level. (American Academy of Pediatrics) [1][2][3][6]
IVIG reduces the need for exchange transfusion in both Rh‑ and ABO‑mediated hemolytic disease. (American Academy of Pediatrics) [1][6]
A repeat IVIG dose may be given after 12 h if bilirubin continues to rise. (American Academy of Pediatrics) [1][2]
Routine use of recombinant erythropoietin and IVIG is no longer recommended because of insufficient efficacy and an increased risk of necrotizing enterocolitis. (American College of Obstetricians and Gynecologists) 5

Prepare for exchange transfusion when TSB reaches the exchange‑transfusion threshold or continues to increase despite phototherapy and IVIG. (American Academy of Pediatrics) [1][6]
Exchange transfusion must be performed by trained personnel in a NICU equipped with full monitoring and resuscitation capabilities. (American Academy of Pediatrics) [1][2]7

Measure TSB 8–12 h after stopping phototherapy and repeat the next day to ensure stability. (American Academy of Pediatrics) 4
Watch for rebound hyperbilirubinemia, which occurs more frequently in hemolytic disease. (American Academy of Pediatrics) [4][2]
Obtain serial hemoglobin checks every 1–2 weeks for the first 6 months to detect late‑onset anemia as maternal antibodies may persist up to 6 months. (American College of Obstetricians and Gynecologists) 5
Consider top‑up red‑cell transfusions if hemoglobin falls markedly and the infant becomes symptomatic. (American Journal of Obstetrics & Gynecology) 8

Do not subtract direct (conjugated) bilirubin from total bilirubin when deciding on phototherapy or exchange transfusion; this can lead to undertreatment. (American Academy of Pediatrics) [1][3]6
Do not delay definitive care by routing the infant to the emergency department when TSB is at exchange‑transfusion levels; admit directly to a pediatric service. (American Academy of Pediatrics) [1][6]7
Do not assume hemolysis has resolved simply because bilirubin normalizes; anemia may develop weeks to months later while maternal antibodies persist. (American College of Obstetricians and Gynecologists) 5
Monitor for neonatal cholestasis with elevated conjugated bilirubin, especially after multiple transfusions, as this can complicate the course. (American Journal of Obstetrics & Gynecology) 8